<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39311022</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-7243</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Inquiry : a journal of medical care organization, provision and financing</Title><ISOAbbreviation>Inquiry</ISOAbbreviation></Journal><ArticleTitle>Use of At-Home Medical Tests Among Older US Adults: A Nationally Representative Survey.</ArticleTitle><Pagination><StartPage>469580241284168</StartPage><MedlinePgn>469580241284168</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">00469580241284168</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/00469580241284168</ELocationID><Abstract><AbstractText>The availability of direct-to-consumer, at-home medical tests has grown over the last decade, but it is unknown how frequently older adults purchase at-home tests, how they perceive such tests, and how interested they are in using at-home tests in the future. We conducted a cross-sectional, nationally representative survey of non-institutionalized US adults aged 50 to 80 about their previous use of, perceptions of, and future intentions to use at-home medical tests. We found that nearly half of older adults (48.1%) have purchased an at-home medical test (95% CI 45.2%-51.0%), including 32.0% (95% CI 29.3%-34.8%) who purchased a COVID-19 test, 16.6% (95% CI 14.7%-18.7%) who purchased an at-home DNA or genetic test, 5.6% (95% CI 4.5%-7.0%) who purchased a screening test for cancer, and 4.4% (95% CI 3.4%-5.6%) who purchased a test for an infection other than COVID-19. Compared with White, non-Hispanic adults, Black, non-Hispanic adults were less likely to have purchased an at-home test (35.5% vs 49.6%, <i>P</i> &lt; .01). Those with a college degree and those with an annual household income greater than $100K were more likely than others to have purchased at-home tests (55.5% vs 42.0%, <i>P</i> &lt; .01; 60.6% vs 39.0%, <i>P</i> &lt; .001, respectively). Most older adults had positive perceptions about at-home tests and expressed interest in using at-home tests in the future. At-home medical testing is now common among older adults. Clinicians should be familiar with different tests that patients can purchase and be prepared to discuss the potential advantages and disadvantages of at-home testing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rager</LastName><ForeName>Joshua B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0001-9557-5672</Identifier><AffiliationInfo><Affiliation>Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regenstrief Institute, Indianapolis, IN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Indiana University Center for Bioethics, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirch</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Dianne C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solway</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malani</LastName><ForeName>Preeti N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>J Scott</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan School of Public Health, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kullgren</LastName><ForeName>Jeffrey T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>University of Michigan, Institute for Healthcare Policy and Innovation, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan Medical School, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Michigan School of Public Health, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs HSR&amp;D, Center for Clinical Management Research, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Inquiry</MedlineTA><NlmUniqueID>0171671</NlmUniqueID><ISSNLinking>0046-9580</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006699" MajorTopicYN="N">Home Care Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">aging research</Keyword><Keyword MajorTopicYN="N">direct-to-consumer testing</Keyword><Keyword MajorTopicYN="N">survey</Keyword></KeywordList><CoiStatement>Data Availability StatementThe National Poll on Healthy Aging regularly releases data from each survey wave for public use at https://www.healthyagingpoll.org/reports-more/data. Those interested in using this dataset should contact the National Poll on Healthy Aging. Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Kullgren reports grant funding from the US National Institutes of Health, the US Department of Veterans Affairs, the Healthwell Foundation, and the State of Michigan Department of Military and Veterans Affairs; receiving consulting fees from the Washington State Office of the Attorney General; receiving honoraria from the American Diabetes Association, the Luxembourg National Research Fund, the Donaghue Foundation, the National Science Foundation, the University of California-Los Angeles, and the University of Pennsylvania. Dr. Kullgren is also supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service and the views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311022</ArticleId><ArticleId IdType="pmc">PMC11421401</ArticleId><ArticleId IdType="doi">10.1177/00469580241284168</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim E, Kojima N, Vangala S, et al.. Impact of COVID-19 on primary care quality measures in an academic integrated health system. J Gen Intern Med. 2022;37(5):1161-1168. doi:10.1007/s11606-021-07193-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07193-7</ArticleId><ArticleId IdType="pmc">PMC8791425</ArticleId><ArticleId IdType="pubmed">35083647</ArticleId></ArticleIdList></Reference><Reference><Citation>
Food and Drug Administration. At-home OTC COVID-19 diagnostic tests. Published March 3, 2023. Accessed March 7, 2023. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/home-otc-covid-19-diagnostic-tests</Citation></Reference><Reference><Citation>
The White House. Fact sheet: The Biden administration to begin distributing at-home, rapid COVID-19 tests to Americans for free. Published January 14, 2022. Accessed March 7, 2023. https://www.whitehouse.gov/briefing-room/statements-releases/2022/01/14/fact-sheet-the-biden-administration-to-begin-distributing-at-home-rapid-covid-19-tests-to-americans-for-free/</Citation></Reference><Reference><Citation>
Food and Drug Administration. Home use tests. Published June 21, 2022. https://www.fda.gov/medical-devices/in-vitro-diagnostics/home-use-tests</Citation></Reference><Reference><Citation>Gronowski AM, Haymond S, Master SR. Improving direct-to-consumer medical testing. JAMA. 2017;318(16):1613-1613. doi:10.1001/jama.2017.13733</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13733</ArticleId><ArticleId IdType="pubmed">29067414</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwell KL. Direct-to-Consumer medical testing in the era of value-based care. JAMA. 2017;317(24):2485-2486. doi:10.1001/jama.2017.5929</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.5929</ArticleId><ArticleId IdType="pubmed">28542699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen DE, Carere DA, Wang C, Roberts JS, Green RC. Diet and exercise changes following direct-to-consumer personal genomic testing. BMC Med Genomics. 2017;10(1):24. doi:10.1186/s12920-017-0258-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0258-1</ArticleId><ArticleId IdType="pmc">PMC5412058</ArticleId><ArticleId IdType="pubmed">28464943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashenhurst JR, Nhan H, Shelton JF, et al.. Prevalence of alpha-1 antitrypsin deficiency, self-reported behavior change, and health care engagement among direct-to-consumer recipients of a personalized genetic risk report. Chest. 2022;161(2):373-381. doi:10.1016/j.chest.2021.09.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.09.041</ArticleId><ArticleId IdType="pubmed">34656525</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn J, Chung WK. 23andMe paves the way for direct-to-consumer genetic health risk tests of limited clinical utility. Ann Intern Med. 2017;167(2):125-126. doi:10.7326/M17-1045</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M17-1045</ArticleId><ArticleId IdType="pubmed">28554190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AWY, White HEG, Plant A, Shipman AR, Shipman KE. Issues surrounding consumer-bought food-allergy testing. Clin Exp Dermatol. 2022;47(3):547-552. doi:10.1111/ced.14978</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ced.14978</ArticleId><ArticleId IdType="pubmed">34655248</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen LM, Lefferts JA. Lessons learned from direct-to-consumer genetic testing. Clin Lab Med. 2020;40(1):83-92. doi:10.1016/j.cll.2019.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2019.11.005</ArticleId><ArticleId IdType="pubmed">32008642</ArticleId></ArticleIdList></Reference><Reference><Citation>Isbell TS. Direct-to-consumer tests on the market today: identifying valuable tests from those with limited utility. Clin Lab Med. 2020;40(1):13-23. doi:10.1016/j.cll.2019.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2019.11.008</ArticleId><ArticleId IdType="pubmed">32008636</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolan NV. Health literacy and the desire to manage one’s own health. Clin Lab Med. 2020;40(1):1-12. doi:10.1016/j.cll.2019.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2019.11.007</ArticleId><ArticleId IdType="pubmed">32008634</ArticleId></ArticleIdList></Reference><Reference><Citation>Woloshin S, Dewitt B, Krishnamurti T, Fischhoff B. Assessing how consumers interpret and act on results from at-home COVID-19 self-test kits: a randomized clinical trial. JAMA Intern Med. 2022;182(3):1-10. doi:10.1001/jamainternmed.2021.8075</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.8075</ArticleId><ArticleId IdType="pmc">PMC8804977</ArticleId><ArticleId IdType="pubmed">35099501</ArticleId></ArticleIdList></Reference><Reference><Citation>Galior KD, Baumann NA. Challenges with at-home | mail-in direct-to-consumer testing: preanalytical error, reporting results, | result interpretation. Clin Lab Med. 2020;40(1):25-36. doi:10.1016/j.cll.2019.11.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2019.11.006</ArticleId><ArticleId IdType="pubmed">32008637</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DT. Self-ordering laboratory testing: limitations when a physician is not part of the model. Clin Lab Med. 2020;40(1):37-49. doi:10.1016/j.cll.2019.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2019.11.002</ArticleId><ArticleId IdType="pubmed">32008638</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilbride MK, Joffe S. The new age of patient autonomy: implications for the patient-physician relationship. JAMA. 2018;320(19):1973-1974. doi:10.1001/jama.2018.14382</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.14382</ArticleId><ArticleId IdType="pmc">PMC6988779</ArticleId><ArticleId IdType="pubmed">30326026</ArticleId></ArticleIdList></Reference><Reference><Citation>Cigolle CT, Langa KM, Kabeto MU, Tian Z, Blaum CS. Geriatric conditions and disability: the health and retirement study. Ann Intern Med. 2007;147(3):156-164. doi:10.7326/0003-4819-147-3-200708070-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-147-3-200708070-00004</ArticleId><ArticleId IdType="pubmed">17679703</ArticleId></ArticleIdList></Reference><Reference><Citation>Charbonneau J, Nicol D, Chalmers D, et al.. Public reactions to direct-to-consumer genetic health tests: a comparison across the US, UK, Japan and Australia. Eur J Hum Genet. 2020;28(3):339-348. doi:10.1038/s41431-019-0529-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-019-0529-8</ArticleId><ArticleId IdType="pmc">PMC7029038</ArticleId><ArticleId IdType="pubmed">31645768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ickenroth MH, Grispen JE, Ronda G, et al.. Motivation and experiences of self-testers regarding tests for cardiovascular risk factors. Health Expect. 2014;17(1):60-72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5060707</ArticleId><ArticleId IdType="pubmed">22032617</ArticleId></ArticleIdList></Reference><Reference><Citation>Bil JP, Prins M, Stolte IG, et al.. Usage of purchased self-tests for HIV and sexually transmitted infections in Amsterdam, the Netherlands: results of population-based and serial cross-sectional studies among the general population and sexual risk groups. BMJ Open. 2017;7(9):e016609. doi:10.1136/bmjopen-2017-016609</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016609</ArticleId><ArticleId IdType="pmc">PMC5623511</ArticleId><ArticleId IdType="pubmed">28939577</ArticleId></ArticleIdList></Reference><Reference><Citation>
Institute for Healthcare Policy and Innovation, University of Michigan. National Poll on Healthy Aging. Accessed March 7, 2023. https://www.healthyagingpoll.org/</Citation></Reference><Reference><Citation>
NORC. Amerispeak. Accessed March 7, 2023. https://amerispeak.norc.org/us/en/amerispeak.html</Citation></Reference><Reference><Citation>Rader B, Gertz A, Iuliano AD, et al.. Use of At-Home COVID-19 Tests - United States, August 23, 2021-March 12, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(13):489-494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8979595</ArticleId><ArticleId IdType="pubmed">35358168</ArticleId></ArticleIdList></Reference><Reference><Citation>Apathy NC, Menser T, Keeran LM, Ford EW, Harle CA, Huerta TR. Trends and gaps in awareness of direct-to-consumer genetic tests from 2007 to 2014. Am J Prev Med. 2018;54(6):806-813. doi:10.1016/j.amepre.2018.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2018.02.013</ArticleId><ArticleId IdType="pubmed">29656919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronda G, Portegijs P, Dinant GJ, Buntinx F, Norg R, van der Weijden T. Use of diagnostic self-tests on body materials among Internet users in the Netherlands: prevalence and correlates of use. BMC Public Health. 2009;9(1):100. doi:10.1186/1471-2458-9-100</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-9-100</ArticleId><ArticleId IdType="pmc">PMC2675528</ArticleId><ArticleId IdType="pubmed">19358708</ArticleId></ArticleIdList></Reference><Reference><Citation>Grispen JE, Ronda G, Dinant GJ, de Vries NK, van der Weijden T. To test or not to test: A cross-sectional survey of the psychosocial determinants of self-testing for cholesterol, glucose, and HIV. BMC Public Health. 2011;11(1):112. doi:10.1186/1471-2458-11-112</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-112</ArticleId><ArticleId IdType="pmc">PMC3045947</ArticleId><ArticleId IdType="pubmed">21329511</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll NM, Blum-Barnett E, Madrid SD, et al.. Demographic differences in the utilization of clinical and direct-to-consumer genetic testing. J Genet Couns. 2020;29(4):634-643. doi:10.1002/jgc4.1193</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgc4.1193</ArticleId><ArticleId IdType="pubmed">31749259</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwell KL. Improving direct-to-consumer medical testing-reply. JAMA. 2017;318(16):1613-1614. doi:10.1001/jama.2017.13756</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13756</ArticleId><ArticleId IdType="pubmed">29067418</ArticleId></ArticleIdList></Reference><Reference><Citation>
Jabbarpour Y, Petterson S, Jetty A, Byun H.
The Health of US Primary Care: A Baseline Scorecard Tracking Support for High-Quality Primary Care. Millibank Memorial Fund; 2023. https://www.milbank.org/publications/health-of-us-primary-care-a-baseline-scorecard/?gad=1&amp;gclid=EAIaIQobChMI_vH4ztX8_gIVp2pvBB16CwQsEAAYASAAEgKp-vD_BwE</Citation></Reference><Reference><Citation>Gill J, Obley AJ, Prasad V. Direct-to-consumer genetic testing: the implications of the US FDA’s first marketing authorization for BRCA mutation testing. JAMA. 2018;319(23):2377-2378. doi:10.1001/jama.2018.5330</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.5330</ArticleId><ArticleId IdType="pubmed">29800087</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshkovits I, Shepshelovich D. Emergency use authorizations of COVID-19-related medical products. JAMA Intern Med. 2022;182(2):228-229. doi:10.1001/jamainternmed.2021.7257</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.7257</ArticleId><ArticleId IdType="pmc">PMC8689422</ArticleId><ArticleId IdType="pubmed">34928303</ArticleId></ArticleIdList></Reference><Reference><Citation>
U.S. Food &amp; Drug Administration. Direct-to-Consumer Tests. U.S. Food &amp; Drug Administration. December
20, 2019. Accessed August 29, 2024. https://www.fda.gov/medical-devices/in-vitro-diagnostics/direct-consumer-tests</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>